FDA Approves Igalmi (Dexmedetomidine) Sublingual Film
Drug Info: ApoThera Drug Disease Clinical Support App - Assess vital signs including orthostatic measurements before administering Mild or Moderate Schizophrenia Agitation - 120 mcg SL or BUC x 1 dose…
Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application
Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as…
Drug Info for Lagevrio (Molnupiravir), Oral Medication for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application
Drug Information for Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Paxlovid (Nirmatrelvir-Ritonavir) and Molnupiravir (Lagevrio), Available on ApoThera Clinical Decision Support Mobile Application Drug Info: ApoThera Drug Disease Clinical…
Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)
Drug Info: ApoThera Drug Disease Clinical Support App Drug Info: ApoThera Drug Disease Clinical Support App Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available…
FDA Pulls Authorization for GSK-Vir’s COVID Therapy, Sotrovimab, as BA.2 Cases Rise
The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology's (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to…
Monoclonal Antibodies for Treating Severe Asthma
Drug Info: ApoThera Drug Disease Clinical Support App ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma: - Cinqair (Reslizumab) - Dupixent (Dupilumab) - Fasenra (Benralizumab) - Tezspire (Tezepelumab)…
COVID-19 PCR Test, COVID-19 Antigen Test and COVID-19 Antibody Test
Drug Info: ApoThera Drug Disease Clinical Support App
Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma
Drug Info: ApoThera Drug Disease Clinical Support App Severe Asthma - 210 mg SC every 4 weeks - Add-on maintenance treatment of severe asthma Missed Dose - Administer dose as…
Opdualag (Nivolumab-Relatlimab), for the Treatment of Melanoma
Drug Info: ApoThera Drug Disease Clinical Support App Melanoma Unresectable or Metastatic - 480mg/160mg IV every 4 weeks - Continue until disease progression or unacceptable toxicity occurs Infusion-related Reactions Grade…